http://afr.com/p/opinion/predator_eyes_pharmaxis_kPP2HzUjXIv0KFpAfHWT2L
Specialty pharmaceutical company Pharmaxis, which has Allan Gray fund manager Simon Marais on the shareholder register with 19.19 per cent, was the subject of takeover speculation over the weekend.
An offshore party is working up a bid proposal and has engaged an investment banking adviser, sources told Street Talk.
A Pharmaxis spokeswoman declined to comment.
Analysts are bullish on Pharmaxis because of its successful launch of Bronchitol in Germany and US Food and Drug Administration acceptance for a standard review of Pharmaxis’s new drug application for cystic fibrosis patients.
[email protected]
[email protected]
The Australian Financial Review
- Forums
- ASX - By Stock
- predator eyes pharmaxis - afr
http://copyright link/p/opinion/predator_eyes_pharmaxis_kPP2HzUjXIv0KFpA...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
MTL
Mantle Minerals' Nick Poll talks to HotCopper on finding gold grades up to 3.57g/t at Mt Berghaus
Add SNT (ASX) to my watchlist
|
|||||
Last
3.3¢ |
Change
-0.001(2.94%) |
Mkt cap ! $39.40M |
Open | High | Low | Value | Volume |
3.4¢ | 3.4¢ | 3.2¢ | $46.51K | 1.381M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 186766 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.4¢ | 196199 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 186766 | 0.033 |
1 | 499893 | 0.032 |
3 | 357258 | 0.031 |
6 | 1195543 | 0.030 |
9 | 1750681 | 0.029 |
Price($) | Vol. | No. |
---|---|---|
0.034 | 196199 | 1 |
0.035 | 300000 | 1 |
0.036 | 243902 | 1 |
0.040 | 400000 | 1 |
0.041 | 14300 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |